Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by PutinKhuylo1on Dec 10, 2019 4:17pm

101 Views

Post# 30441250

RE:RE:Seeking alpha article

You can't really put much credence into a "research" article which completely ignores the value of the science behind the pipeline, which most of the knowledgeable folks I've talked to have pegged at "9, possibly 10 figures $US." Which alone is worth way more than .42 per share. Very limited article rehashing the same cr*p without taking the time to do a little digging.

Bullboard Posts

Transportation technology stock secures second major contract in a week